FDA Law Blog: Biosimilars
MARCH 23, 2025
By Deborah L. Livornese On Friday, March 21, 2025, FDA announced that it was further delaying the effective date for the ACNU final rule until May 27, 2025. We wrote about the December 26, 2024 publication of the final rule (89 FR 105288) here. Originally, the Nonprescription Drug Product with an Additional Condition for Nonprescription Use (ACNU) final rule was to become effective January 27, 2025.
EMCrit Project
MARCH 23, 2025
A discussion of some arterial line philosophy, accuracy, and ease of placement. EMCrit Project by Scott Weingart, MD FCCM.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
MARCH 23, 2025
In a debate at the 2025 APhA Annual Meeting, speakers highlighted GLP-1s advantages in stroke prevention and weight loss vs SGLT2s superiority in heart failure, CV death reduction, and renal protection.
EMCrit Project
MARCH 23, 2025
Let's talk about starting patients on milrinone. Milrinone is part of a group of medications that I would regard as quasi-titratable. They have an awkward half-life of roughly ~0.5-3 hours. Other medications in this group might include diltiazem, labetalol, and perhaps nicardipine. These drugs can be given as a continuous infusion, but they're not easy […] EMCrit Project by Josh Farkas.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Pharmacy Times
MARCH 23, 2025
Jeff A. Goad, PharmD, MPH, discusses the latest RSV vaccination guidelines and recommendations for 2025, highlighting vaccine options, target populations, timing considerations, evolving CDC policies, and the role of pharmacists in immunization efforts.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharmacy Times
MARCH 23, 2025
Pharmacists are pivotal in expanding reproductive health care access through patient education and collaboration.
Pharmacy Joe
MARCH 23, 2025
In this episode, Ill discuss high-dose insulin euglycemic therapy in the treatment of a patient with massive caffeine overdose. Episode 1011: High Dose Insulin For Massive Caffeine Overdose Subscribe on iTunes , Android , or Stitcher Many cardiotoxic medication overdoses appear to respond to high dose insulin euglycemia therapy, including beta-blockers, calcium channel blockers, and tricyclic antidepressants.
Pharmacy Times
MARCH 23, 2025
Automation can enhance medication management and support pharmacists' critical clinical roles.
Med Ed 101
MARCH 23, 2025
Modafinil (Provigil) is a stimulant type of medication that is most often utilized in narcolepsy. In my geriatric practice, I do see occasional off-label use to help stimulate energy in patients who are experiencing fatigue. I’ll outline my top 5 modafinil clinical pearls. Modafinil Clinical Pearls Polypharmacy is a problem in my geriatric patient population. […] The post Top 5 Modafinil Clinical Pearls appeared first on Med Ed 101.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
MARCH 23, 2025
Pharmacists are leading the way in personalized medicine through strategic pharmacogenetic implementation.
The Guardian - Pharmaceutical Industry
MARCH 23, 2025
Corporate backsliding on climate and diversity policies mean this years annual meetings may be tough for some of the UKs biggest companies The leafy surroundings of Sunbury-on-Thames in Surrey will provide an unlikely backdrop for potentially one of the most explosive events of an intriguing shareholder meeting season, as corporate Britain grapples with a rapidly shifting geopolitical backdrop.
Expert insights. Personalized for you.
59 
Let's personalize your content